Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Glaukos (GKOS) EBITDA (2016 - 2025)

Glaukos (GKOS) has disclosed EBITDA for 12 consecutive years, with $19.2 million as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA rose 166.95% to $19.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$40.5 million, a 66.87% increase, with the full-year FY2025 number at -$40.5 million, up 66.87% from a year prior.
  • EBITDA was $19.2 million for Q4 2025 at Glaukos, up from -$16.4 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $19.2 million in Q4 2025 to a low of -$39.1 million in Q1 2024.
  • A 5-year average of -$19.2 million and a median of -$23.7 million in 2024 define the central range for EBITDA.
  • Peak YoY movement for EBITDA: surged 189.25% in 2021, then plummeted 824.37% in 2022.
  • Glaukos' EBITDA stood at $4.7 million in 2021, then tumbled by 824.37% to -$33.7 million in 2022, then dropped by 14.49% to -$38.6 million in 2023, then increased by 25.78% to -$28.7 million in 2024, then soared by 166.95% to $19.2 million in 2025.
  • Per Business Quant, the three most recent readings for GKOS's EBITDA are $19.2 million (Q4 2025), -$16.4 million (Q3 2025), and -$22.7 million (Q2 2025).